MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway
出版年份 2019 全文链接
标题
MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway
作者
关键词
miR-6875-3p, BTG2, Proliferation, Invasion, Metastasis, HCC
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-01-09
DOI
10.1186/s13046-018-1020-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway
- (2018) Rongchang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- CD31 regulates metastasis by inducing epithelial–mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway
- (2018) Yuan-Yuan Zhang et al. CANCER LETTERS
- A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer
- (2018) Sipeng Shen et al. Molecular Oncology
- PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma
- (2018) Hai Jiang et al. Cancer Medicine
- BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells
- (2017) Ke-Hung Tsui et al. Cancer Medicine
- MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma
- (2016) Jing-Song Chen et al. CANCER LETTERS
- Novel combination of serum microRNA for detecting breast cancer in the early stage
- (2016) Akihiko Shimomura et al. CANCER SCIENCE
- MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer
- (2016) Taiki Kijima et al. ONCOLOGY REPORTS
- Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes
- (2015) J-A Choi et al. ONCOGENE
- Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Qing-Min Fan et al. CANCER LETTERS
- BTG2: A rising star of tumor suppressors (Review)
- (2014) BIJING MAO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular Biology of Liver Cancer Stem Cells
- (2014) Naoki Oishi et al. Liver Cancer
- Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients
- (2013) N Wagener et al. BRITISH JOURNAL OF CANCER
- Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients
- (2013) Yu-Cheng Ma et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells
- (2013) Yan-jun Zhang et al. TUMOR BIOLOGY
- BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria
- (2012) Seo-Kyung Lim et al. CLINICAL & EXPERIMENTAL METASTASIS
- BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition
- (2012) V Coppola et al. ONCOGENE
- Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib
- (2011) F Takahashi et al. ONCOGENE
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now